Symrise invests in Synergio
Symrise has made an unspecified investment to take a minority stake in Israeli biotech Synergio, with the option of owning a majority in future. Financial terms are not being disclosed.
Based in Jerusalem, Synergio specialises in developing natural antimicrobial combinations from plants for product protection, using a data-driven, biochemistry-based, computational platform. Symrise is already a major player in this field within the personal care sector and sees growth opportunities in working together with Synergio.
“Synergio’s bioactives fit seamlessly into our Product Protection portfolio, said Dr Joern Andreas, president scent and care at Symrise. “The partnership will accelerate the development of broad-spectrum antimicrobial solutions.”
RELATED ARTICLES
UK-based speciality chemicals company Elementis has announced that, by mutual agreement, CEO Paul Waterman will step down no later than the AGM in April 2025, remaining available as required for any transition or other support until the end of July. A successor is now being sought.
International Chemical Investors Group (ICIG), the owner of WeylChem and many other European chemical assets, has acquired the European Advanced Organics business of Valtris Specialty Chemicals.
BASF has formed a partnership with Slovenian white biotech Acies Bio. Under this it will further develop the latter’s OneCarbonBio fermentation platform to derive methanol for the production of fatty alcohols for home and personal care ingredients, notably surfactants.
A pilot enforcement project carried out by national enforcement authorities in 13 European Economic Area (EEA) countries between November 2023 and April 2024 found that 6% of about 4,500 cosmetic products inspected contained hazardous substances.
Spanish energy and chemicals company Cepsa has renamed itself Moeve.
India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach Group in a move that it said would “create a global pigment company, combining SCIL’s operations and expertise with Heubach’s technological capabilities”. Terms were not disclosed.
